The DSC2 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HAP1 human cell line, designed to disrupt the DSC2 gene. This polyclonal population provides a heterogeneous loss-of-function model for studying desmocollin-2 biology without isolation of single-cell clones. The knockout is generated through CRISPR/Cas9-mediated gene disruption, resulting in a diverse pool of cells carrying various edits at the DSC2 locus. This format offers researchers a robust tool for investigating desmosomal adhesion and related signaling pathways in a near-haploid genetic background.
The HAP1 host cell line is a near-haploid human cell line derived from a patient with chronic myeloid leukemia, characterized by a haploid karyotype and adherent growth. Its haploid nature simplifies genetic manipulation and analysis, making it an ideal model for knockout studies. The HAP1 background provides a consistent cellular context with well-characterized growth properties, facilitating reproducible functional assays. This cell line’s genetic tractability supports CRISPR/Cas9 editing, allowing efficient generation of gene knockouts while maintaining key cellular functions relevant to adhesion and signaling.
DSC2 encodes desmocollin-2, a calcium-dependent desmosomal cadherin essential for intercellular adhesion and desmosome assembly. Desmocollin-2 functions as a transmembrane adhesion receptor, forming complexes with desmoglein-2, plakoglobin, plakophilin-2, and desmoplakin, which link to keratin intermediate filaments and desmin. The expression of DSC2 is regulated by upstream factors including TP63, AP-1 transcription factors, Wnt/??-catenin signaling, and mechanical tension. Downstream, desmocollin-2-mediated adhesion influences the localization and stability of desmoplakin, plakoglobin, and plakophilin-2, thereby modulating cytoskeletal organization and tissue integrity. This network is critical for maintaining epithelial and cardiac muscle structure, with disruptions leading to pathogenic conditions.
In the HAP1 cell line, DSC2 knockout disrupts desmosomal cadherin function, impairing cell-cell adhesion and desmosome assembly. This model is particularly relevant for studying arrhythmogenic right ventricular cardiomyopathy, palmoplantar keratoderma, and woolly hair syndrome, all associated with DSC2 mutations. The near-haploid background allows clear phenotypic interpretation of loss-of-function effects on adhesion-dependent signaling pathways, including Wnt/??-catenin and mechanical sensing. Consequently, these polyclonal knockout cells serve as a valuable system for dissecting DSC2-dependent mechanisms in cardiac and epithelial biology, where compromised desmosomes lead to tissue fragility and disease.
Research applications span desmosome biology, cell adhesion research, drug screening for desmosomal diseases, and CRISPR knockout validation. Researchers can employ a range of assays, including Western blotting and RT-qPCR for expression analysis, immunofluorescence and flow cytometry for protein localization and surface expression, cell aggregation assays to assess adhesion strength, and co-immunoprecipitation for interaction studies. RNA-seq enables transcriptomic profiling to uncover pathway alterations. These tools facilitate investigations into DSC2’s role in cell-cell adhesion and signaling, advancing understanding of desmosome-related pathologies and therapeutic interventions. For additional technical details or inquiries, please contact Ascent Research.
